Currently holds positions in Creative Realities Inc and Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | Creative Realities Inc | Aug. 20, 2014 - |
Independent Director | Apellis Pharmaceuticals Inc | Sept. 1, 2009 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-11-20 | 2023-11-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.3%
47.7459,675 USD |
1,250 -0.3% | 47.74 | 59,675 USD | |
2023-10-18 | 2023-10-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.3%
48.5060,625 USD |
1,250 -0.3% | 48.50 | 60,625 USD | |
2023-09-19 | 2023-09-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.3%
45.0056,250 USD |
1,250 -0.3% | 45.00 | 56,250 USD | |
2023-07-18 | 2023-07-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
64.7980,988 USD |
1,250 -0.5% | 64.79 | 80,988 USD | |
2023-06-21 | 2023-06-20 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
88.41110,513 USD |
1,250 -0.5% | 88.41 | 110,513 USD | |
2023-05-18 | 2023-05-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
88.66110,825 USD |
1,250 -0.5% | 88.66 | 110,825 USD | |
2023-04-18 | 2023-04-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
81.05101,313 USD |
1,250 -0.5% | 81.05 | 101,313 USD | |
2023-02-21 | 2023-02-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
52.3865,475 USD |
1,250 -0.5% | 52.38 | 65,475 USD | |
2023-01-19 | 2023-01-17 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
52.4265,525 USD |
1,250 -0.5% | 52.42 | 65,525 USD | |
2022-12-19 | 2022-12-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
52.3565,438 USD |
1,250 -0.5% | 52.35 | 65,438 USD | |
2022-11-17 | 2022-11-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
48.0160,013 USD |
1,250 -0.5% | 48.01 | 60,013 USD | |
2022-10-17 | 2022-10-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
59.3174,138 USD |
1,250 -0.5% | 59.31 | 74,138 USD | |
2022-09-16 | 2022-09-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
66.0082,500 USD |
1,250 -0.5% | 66.00 | 82,500 USD | |
2022-08-16 | 2022-08-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
67.2184,013 USD |
1,250 -0.5% | 67.21 | 84,013 USD | |
2022-07-18 | 2022-07-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
46.3357,913 USD |
1,250 -0.5% | 46.33 | 57,913 USD | |
2022-04-18 | 2022-04-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
50.9063,625 USD |
1,250 -0.5% | 50.90 | 63,625 USD | |
2022-03-17 | 2022-03-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.5%
39.5749,463 USD |
1,250 -0.5% | 39.57 | 49,463 USD | |
2022-01-19 | 2022-01-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
1,250
-0.2%
40.5650,700 USD |
1,250 -0.2% | 40.56 | 50,700 USD | |
2021-12-17 | 2021-12-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
3,000
-0.4%
42.88128,640 USD |
3,000 -0.4% | 42.88 | 128,640 USD | |
2021-11-17 | 2021-11-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
3,000
-0.4%
43.50130,500 USD |
3,000 -0.4% | 43.50 | 130,500 USD | |
2021-11-17 | 2021-11-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
3,000
-0.4%
35.00105,000 USD |
3,000 -0.4% | 35.00 | 105,000 USD | |
2021-05-18 | 2021-05-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
45.39113,475 USD |
2,500 -0.4% | 45.39 | 113,475 USD | |
2021-03-17 | 2021-03-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
46.77116,925 USD |
2,500 -0.4% | 46.77 | 116,925 USD | |
2021-02-17 | 2021-02-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
46.00115,000 USD |
2,500 -0.4% | 46.00 | 115,000 USD | |
2021-01-19 | 2021-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
53.15132,875 USD |
2,500 -0.4% | 53.15 | 132,875 USD | |
2020-12-16 | 2020-12-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
52.16130,400 USD |
2,500 -0.4% | 52.16 | 130,400 USD | |
2020-11-17 | 2020-11-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
39.3898,450 USD |
2,500 -0.4% | 39.38 | 98,450 USD | |
2020-10-16 | 2020-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
35.0087,500 USD |
2,500 -0.4% | 35.00 | 87,500 USD | |
2020-10-09 | 2020-10-07 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
7,500
-1.1%
35.00262,500 USD |
7,500 -1.1% | 35.00 | 262,500 USD | |
2020-06-16 | 2020-06-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
30.2175,525 USD |
2,500 -0.4% | 30.21 | 75,525 USD | |
2020-05-19 | 2020-05-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
30.0075,000 USD |
2,500 -0.4% | 30.00 | 75,000 USD | |
2020-04-17 | 2020-04-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
30.0075,000 USD |
2,500 -0.4% | 30.00 | 75,000 USD | |
2020-03-26 | 2020-03-25 |
Apellis Pharmaceuticals Inc
(APLS)
|
PS Planned sale |
2,500
-0.4%
30.0075,000 USD |
2,500 -0.4% | 30.00 | 75,000 USD | |
2020-02-19 | 2020-02-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
2,500
-0.4%
42.35105,875 USD |
2,500 -0.4% | 42.35 | 105,875 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
S Sale |
2,500
-0.4%
41.47103,675 USD |
2,500 -0.4% | 41.47 | 103,675 USD |